Should I buy MaxLinear, Inc. (MXL) stock or is it too late?
⭐ The most reliable of them, either direction: Stifel — 58% of its targets hit on this sector (192 calls tested). It aims for $120 (+89 %), call made on July 25, 2026, maturing on July 25, 2027 (34 d ago).
Firm-by-firm track record on MaxLinear, Inc.
| Firm | % right | Gain vs sector | Calls | Aims for |
|---|---|---|---|---|
| Stifel | 72 % | +57.1 % | 18 | $120 +89% |
| Roth Capital | 67 % | +54.1 % | 6 | $100 +58% |
| Benchmark | 56 % | +44.3 % | 16 | $28 -56% |
| Northland Capital Markets | 60 % | +30.6 % | 5 | $28 -57% |
| Deutsche Bank | 67 % | +19.5 % | 9 | $45 -29% |
| Needham | 44 % | +4.2 % | 18 | $100 +58% |
| Susquehanna | 33 % | -20.3 % | 9 | $80 +26% |
✅ Reasons to believe
- 67% of analysts rate it a buy (Buy consensus, 6 ratings) — a sign of market conviction.
- Median price target $98, i.e. +54% from the current price ($63).
- The most reliable firm on MXL, Stifel (72% hit rate, 18 scored calls), targets $120 (call made on July 24, 2026, maturing on July 24, 2027) (+89%) in its most recent call, and $49 (call made on April 24, 2026, maturing on April 24, 2027) (-23%) in the one coming due soonest.
⚠️ Reasons to hesitate
- The consensus is not unanimous: of 6 ratings, 2 are neutral.
- A 12-month target is not a guaranteed path: the price can fall in the meantime.
- Volatile stock: sharp swings — including steep drops — are part of its profile.
- No dividend: your return depends only on price appreciation.
The analyst consensus on MXL
Median target $98 (+54%) · 6 ratings · Buy consensus
⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.
Frequently asked questions
Should you invest in MaxLinear, Inc. now?
We won't decide for you. The facts: 67% of analysts rate it a buy, median target $98 (+54%), and Stifel (most reliable on MXL, 72%) targets $120. Weigh that against valuation and volatility. This is not personalized advice.
Is it too late to invest in MaxLinear, Inc.?
Not according to analysts: the median target ($98) is still +54% above the current price ($63) (most reliable on MXL: Stifel, 72%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.
Is MaxLinear, Inc. still worth investing in?
It depends on the gap between the price ($63) and its estimated value: analysts target $98 on median (+54%), with 67% buys (most reliable on MXL: Stifel, 72%). Cross-check with their real reliability on MXL and the cautions above. Information, not advice.
What's the main risk in buying MXL?
The consensus is not unanimous: of 6 ratings, 2 are neutral.
→ Go deeper: the full MaxLinear, Inc. profile (consensus, analyst reliability, price target, performance).